In this episode, Joe Moore and Kyle Buller interview CEO & Co-founder of Nue Life, Juan Pablo Cappello, from his home in Miami during the Wonderland conference. Cappello first talks about growing up in Chile, his family’s relationship with San Pedro, his entrepreneurial past (starting the first online bank in Latin America), and how selling that company for $700 million felt like an abject failure. And he discusses how the idea of depression and PTSD being symptoms of an unaddressed root cause led to the creation of Nue Life, and what he wants to do with what he considers a primarily data-based company: use the massive amounts of data connected devices are already harvesting from us (digital phenotyping) for our benefit rather than our detriment. He believes most medical models focus primarily on the continued income from maintenance medications like antidepressants, and instead, A.I. could use this data to recognize patterns in behavior and make recommendations based on each user’s specific data points – a sort of health ecosystem attuned to what works best for each person.

The post PT274 – Juan Pablo Cappello – Nue Life: Using Digital Phenotyping to Personalize Healthcare appeared first on Psychedelics Today.

Previous articleHAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada
Next articlePsychedelic and Mysticism: The Debate Continues